Skip to main content
Log in

Pravastatin has no direct effect on transmembrane cationic transport systems in human erythrocytes and platelets

  • Pharmacokinetics and Disposition
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

In vitro incubation of human erythrocytes and platelets with the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor pravastatin in the concentration range 1 nM to 10μM did not affect the activity of the Na+−K+-pump, Na+−K+-cotransport or Na+−Li+-countertransport, or the ground membrane leak for Na+ and K+.

The data indicate that pravastatin has no direct effect on transmembrane cationic transport systems in red blood cells or platelets.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lijnen P, Celis H, Fagard R, Staessen J, Thijs L, Amery A (1994) Influence of cholesterol lowering on plasma membrane lipids and cationic transport systems. J Hypertension 12: 59–64

    CAS  Google Scholar 

  2. Levy Y, Leibowitz R, Aviram M, Brook JC, Cogan V (1992) Reduction of plasma cholesterol by lovastatin normalizes erythrocyte membrane fluidity in patients with severe hypercholesterolaemia. Br J Clin Pharmacol 34: 427–430

    PubMed  CAS  Google Scholar 

  3. Singhvi SM, Pan HY, Morrison RA, Willard DA (1990) Disposition of pravastatin sodium, a tissue-selective HMG-CoA reductase inhibitor, in healthy subjects. Br J Clin Pharmacol 29: 239–243

    PubMed  CAS  Google Scholar 

  4. Lijnen P, Hespel P, Lommelen L, Laermans M, M'Buyamba-Kabangu JR, Amery A (1986) Intracellular sodium, potassium and magnesium concentration, ouabain-sensitive86Rb-uptake and sodium efflux and Na+, K+-cotransport activity in erythrocytes of normal male subjects studied at two occasions. Methods Find Exp Clin Pharmacol 8: 525–533

    PubMed  CAS  Google Scholar 

  5. Garay RP, Nazaret C, Diez J, Etienne A, Bourgain R, Braquet P (1984) Stimulation of K+ fluxes by diuretic drugs in human red cells. Biochem Pharmacol 33: 2013–2020

    Article  PubMed  CAS  Google Scholar 

  6. Turaihi K, Khokher MA, Barradas MA, Mikhailidis DP, Dandona P (1989)86Rb (K) influx and3H-ouabain binding by human platelets: evidence for β-adrenergic stimulation of Na, K-AT-Pase activity. Metabolism 38: 773–776

    Article  PubMed  CAS  Google Scholar 

  7. Kimmelberg HK (1975) Alterations in phospholipid dependent (Na−K)ATPase activity due to lipid fluidity. Biochim Biophys Acta 413: 143–146

    Article  Google Scholar 

  8. Levy R, Hevroni D, Chbantchik ZI, Livine A (1986) Lii−Nao countertransport and Li-leak in erythrocytes are differentially affected by membrane enrichment with cholesterol hemisuccinate. Biochim Biophys Acta 854:325–328

    Article  PubMed  CAS  Google Scholar 

  9. Claret M, Garay R, Giraud F (1978) The effect of membrane cholesterol on the sodium pump in red blood cells. J Physiol 274:247–263

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lijnen, P., Petrov, V. & Amery, A. Pravastatin has no direct effect on transmembrane cationic transport systems in human erythrocytes and platelets. Eur J Clin Pharmacol 47, 281–283 (1994). https://doi.org/10.1007/BF02570509

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02570509

Key words

Navigation